Bipolar Disorder Study for Men and Women

Completed · Phase 3

Conditions studied: Bipolar Disorder

In brief

A Placebo Controlled Study Evaluating Efficacy and Safety of Medication in Patients with Bipolar Disorder

Key facts

Study ID

NCT00056277

Run by

GlaxoSmithKline

People needed

150

Starts

2003-02-27

Expected to finish

2005-12-14

Last updated by the study team

2017-04-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must provide written and informed consent
• Diagnosis of Bipolar I Disorder and currently depressed for minimum of the previous 8 weeks
• Patients must have been hospitalized for mood disorder or incarceration with or without formal charges as the result of mania related behavior

You may not qualify if…

• Patients must not be suicidal
• Patients must not have a history or non-response to antidepressant treatment
• Patients must not have a clinical history of substance dependence in the past year or abuse within the 4 weeks prior to study entry
• Patients must not have had epilepsy or hypothyroidism

Where it is running

• GSK Investigational Site — Beverly Hills, California, United States
• GSK Investigational Site — La Jolla, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — Santa Ana, California, United States
• GSK Investigational Site — Marietta, Georgia, United States
• GSK Investigational Site — Terre Haute, Indiana, United States
• GSK Investigational Site — Shreveport, Louisiana, United States
• GSK Investigational Site — Saint Charles, Missouri, United States
• GSK Investigational Site — Princeton, New Jersey, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — Pleasantville, New York, United States
• GSK Investigational Site — Raleigh, North Carolina, United States
• GSK Investigational Site — Brecksville, Ohio, United States
• GSK Investigational Site — Cincinnati, Ohio, United States
• GSK Investigational Site — Cleveland, Ohio, United States
• GSK Investigational Site — Eugene, Oregon, United States
• GSK Investigational Site — Portland, Oregon, United States
• GSK Investigational Site — Columbia, South Carolina, United States
• GSK Investigational Site — San Antonio, Texas, United States
• GSK Investigational Site — Brown Deer, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.